Journal profile · Immunology
Bone Marrow Transplantation
ISSN 0268-3369 · eISSN 1476-5365 · Springer Nature · ENGLAND · Semimonthly · Founded 1997
Bone Marrow Transplantation: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.04; hybrid open access; APC about USD 4,990; median 121 days to acceptance (103 articles, last 24 months); community-reported acceptance: fairly easy; 292 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Bone Marrow Transplantation is published by Springer Nature and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Acute Lymphoblastic Leukemia research, together about 42% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Ranking in the top quartile of hematology and trasnplantation journals worldwide, we are the official publication of the EBMT. We provide wide exposure and high visibility for your publication through our nature.com platform, and we also offer funder-compliant open access options. We publish high quality, peer reviewed original research and reviews across all aspects of basic biology and clinical use of haemopoietic cell transplantation. World's leading voices in the field form our expert editorial team, providing attractive turnaround times from first decision to publication. We provide high levels of author satisfaction, with 99% of our published authors reporting that they would definitely or probably publish with us again.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hematopoietic Stem Cell TransplantationMedicine28%
- Acute Myeloid Leukemia ResearchMedicine7.7%
- Acute Lymphoblastic Leukemia researchMedicine6.3%
- Immune Cell Function and InteractionImmunology and Microbiology5%
- Polyomavirus and related diseasesMedicine4.3%
- T-cell and B-cell ImmunologyImmunology and Microbiology3.9%
- Lymphoma Diagnosis and TreatmentMedicine3.8%
- Multiple Myeloma Research and TreatmentsMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Transplantation | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Hematology | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Transplantation | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Transplantation | Zone 2 |
| Minor | Hematology | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, OCLC
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.04LetPub ·
- Impact factor (publisher) 2025
- 5.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.7Publisher website ·
- CiteScore 2026-06
- 7.6LetPub ·
- SJR 2026-06
- 1.7LetPub ·
- SNIP 2026-06
- 1.5LetPub ·
- h-index
- 119LetPub ·
- h-index
- 172OpenAlex ·
- i10-index
- 7,016OpenAlex ·
- 2-year mean citedness
- 3.21OpenAlex ·
- Self-citation rate
- 9.8%LetPub ·
- Share of gold OA articles
- 36.08%LetPub ·
Volume
- Articles per year
- 145LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 2,395,337Publisher website ·
Articles by year OpenAlex count · 11,923 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 254 | 90 | 70 |
| 2025 | 292 | 132 | 882 |
| 2024 | 322 | 172 | 1,838 |
| 2023 | 262 | 144 | 2,157 |
| 2022 | 371 | 183 | 4,386 |
| 2021 | 373 | 196 | 5,020 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
121 daysMedian, submission to acceptance · P25–P75 85 days – 179 days
- Acceptance to online
- median 14 days (103 articles)
- Submission to online
- median 138 days
- Sample
- 103 articles with submission and acceptance dates (640 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,990 / EUR 3,990 / GBP 3,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1997
- ISSN
- 0268-3369
- Electronic ISSN
- 1476-5365
- Society / sponsor
- EBMT
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Bone Marrow Transplantation
What CAS zone is Bone Marrow Transplantation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Bone Marrow Transplantation is in Zone 2 of Medicine, and in Zone 2 of the minor category Hematology / Immunology / Transplantation / Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Bone Marrow Transplantation?
The latest impact factor listed by LetPub is 5.04; CiteScore 7.6, h-index 172.
How long does peer review take at Bone Marrow Transplantation?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 121 days (interquartile range 85–179 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Bone Marrow Transplantation?
According to LetPub and DOAJ records, Bone Marrow Transplantation is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and Current Contents; that list has not been checked against each database.
Is Bone Marrow Transplantation open access, and what is the APC?
Bone Marrow Transplantation is a hybrid journal. For open-access publication: APC about USD 4,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .